Chanelle Medical

Chanelle Pharma, through its division Chanelle Medical, is Ireland's largest indigenous manufacturer of generic pharmaceuticals for both human and animal health. The company specializes in the development, registration, and manufacture of complex generic products across a wide range of therapeutic areas, including cardiovascular, central nervous system, and musculoskeletal health. Operating from state-of-the-art GMP-certified facilities in Loughrea, Ireland, Chanelle provides comprehensive CDMO services to global pharmaceutical partners. In early 2024, the company was acquired by Exponent Private Equity to drive further international expansion and enhance its product development capabilities. With a presence in over 90 countries, Chanelle is a key player in the global supply of affordable, high-quality generic medicines.